{"name":"UCB Korea Co., Ltd.","slug":"ucb-korea-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPNF9YNzZfNFdvblZJeV9YWWViZVBLY1pxZlZ6LVZUVktXaGtwaXluejduNnVZNFhLay1lZmlXWnV3THJMNVMxNGpQczZnNTNhVEJlSk05dGxNeDlJV0VVR2l3bkVtZkFvZE5RLWE5VEQwMFBSSm5oeVcxMVBlTnVEMXZHTHRsX3ZfQkdMVkZEMXNxUi1CMm00bm5feER1aHZPXzZOeVY4cXpIeVZWR3cxUWtMQUpOWmpjNWZCdDJaUHdmYm1ROFZCQkcyNDA2WlY0bGN1R2hnOGNNQndvNzJQQmFBV2Nqb0RjOWYzbm1IWlVQRXdtV1JRQ1FGSXhwTnZXX0xTbi1jNA?oc=5","date":"2026-03-03","type":"deal","source":"prnewswire.com","summary":"Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases - prnewswire.com","headline":"Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wJBVV95cUxNcEd6Rkt1MDFqcjhKb3lGcFJKT0dKOUFfcS1aOUtKTEtXMzB0Mzd3dGF1NGRlTExhMGQ4dGFVMEhFaDhLZ1RiSEpMb0VqWGZtVmFXM1ZQUHF2cnQ0UEVkT0ExeEticlFxaTA5NDZYY1BWQ3B5cWJPU2hsWjBwZGthR0plc18wNUhJNzA5enpJOTRTUURWV3pvclpwbVdJcnMxR0x4WVdmY21MQktTYTdDdFBWYmxqMkR0T2RFNEotZGc4SUxGNG9PNVRIblpvTWJJSjNGTU1xX1BQT0YxeFRSNENReGpUeTR1WDZLZm1EN2MxM2JrYlJXeHUzU3BQSFV6MVBrSEZ3MnhYLUNFVXlSLUxsUG0wMWlnVDdmcC14YUVMNjZFMmhpUWMzUjlwYWJxbTVuSF9qX215VnFPdGNpUjZHTll3MTI1UTBVNHAyVkQ0WXVpRHdnVS1tVGtUbndRU0NF?oc=5","date":"2025-12-11","type":"deal","source":"prnewswire.com","summary":"Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights - prne","headline":"Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Ex","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOTmpFdDRVUlNMNXhpS2hfMjcxRWg3WVdjOTRqYjlFbi0yWUF1TWFWanFTZlR4TmZoNXJkRGFtSHhRMzJ4eUMtdlp6WWhYaHRTU0VzeFVmOGlnMlpYX1RDd3MwMFZva2Y4Yl9rN0dMOGc2VzN4WVR1Qk1FR3RERnZYOXlRZE8yMVczNEpoR0RHQmNqVEdOTko0QWFPa3l2Q3lZQ0E?oc=5","date":"2025-11-16","type":"pipeline","source":"Business Weekly","summary":"Cambridge jobs to go in Nxera Pharma's restructuring blueprint - Business Weekly","headline":"Cambridge jobs to go in Nxera Pharma's restructuring blueprint","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNRDZSdTB0WWxNRUhRYVg0WEh0aHUxaERDZ0Q2cDZ3OWlFbkU4aG5oQXpsc3I1R2xZT3Y2elRsSDVKeTRWWk5Cc213eUNkeXlQZ0RFbGJiaTd1N2VyWDZYRWRGMzBVREs2VHdYRE4yczRVQnRKVkZ0c0ZiVEVTdzQ4c281Sm8tcFYxbFZhdjhZeTU5NnJESm8xOGZUeTJCZktScHZLcFBwdnhWQ3U2dGtQaUZuREhPdjFUWXMtNzhvdDA5UDkwODdSbUs3Zl9Hb2h5S2lvR1RBUUNjZlMtWlh3R2N1eXFfQQ?oc=5","date":"2025-10-01","type":"deal","source":"businesswire.com","summary":"Tanner Pharma Group and UCB Pharma Initiate Partnership for Epilepsy Program in Southeast Asia - businesswire.com","headline":"Tanner Pharma Group and UCB Pharma Initiate Partnership for Epilepsy Program in Southeast Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPWmdydm41akl6Y3VGd1NUSlFObGxQOU93MEswRWpUdEFjNFpUWkRFZnhVTXNwcG9nWTBtZFB5ak5RMjlaVi1NUFR6TzZHRkJlZmwwa1FxMHVQRzVlQ0tzdzNaTThfRkhmZFZISWxGRjZiNWxYbGQ3aDRNbkZnNThhTzc0dGtPaFRIR29tR1hpMUFwZkJMQWJHOS1WdWJzS3FWdFBlSWVR?oc=5","date":"2025-06-14","type":"pipeline","source":"Global Atlanta","summary":"Belgian Pharma Giant With Atlanta Base to Invest Billions in U.S. Factory - Global Atlanta","headline":"Belgian Pharma Giant With Atlanta Base to Invest Billions in U.S. Factory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPTEEzWTdwZG9TcW9oNzMzQVRveUJIUWI3UHFfQ3FBeWczbFN0eTNoLWM0Z3hTeVItWUFxN2NRNFNzaldKMmJvMXNjYUFvMld5T1hLdDNsYjVwTmVkaENIeHdXTlVfdjV5eVlkdjZqRVhxXzd6elBXaTZhTlVVR05ENGE5enRvYU5pcGFoUFZDTDlrNThyazJ2S1dmeTVuc2lvT3R4N2hjeW12WVEyaERoRTdWY0Q2Vl8tNVpoY0tUazZURnZ3akwxNA?oc=5","date":"2025-01-21","type":"pipeline","source":"Citeline News & Insights","summary":"The World’s Top 100 Pharma Companies: 2024 Sales Rankings - Citeline News & Insights","headline":"The World’s Top 100 Pharma Companies: 2024 Sales Rankings - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQb19nQV9UbEo1MENSN3dOTHdtZHNuNkNuMFc5U3hKakZDUnVfeGhtdEk1YmVYbmZ3eUNBMk1MVkJCLWFrVmI3Z0tsdS1FbDVPYWttek5zQkZxU2ZzM2VLZFo4VWtfOTdSd0Z1YVU1c1VEWmxocHR5NVlLRU9FSUNhbDBRRW1iNi12ZGc0MElaV2kwNk4yTGJ1QW1CTWk3aEhyZzhmRkNXUHVFMnk4Vkw1WEpNVzJaQ3RaVnBmTA?oc=5","date":"2025-01-09","type":"pipeline","source":"Bain & Company","summary":"An Optimistic Growth Outlook in Asia-Pacific - Bain & Company","headline":"An Optimistic Growth Outlook in Asia-Pacific - Bain & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOaU9nTG9aOWh5TUowOFdWd1dpT193MXh5Q2J3VUxHWFYyS3pJZW1IdGFYbXQ0VUxHRXlPUUFNNEkxaFhKcXktSmJoQmt3U0EyQVZYTGlHQkl3NlZDRzlCQjhQZ0pRTW9JOW9HcXE2RnJ4VjJRMXhDc3NDandpOFkwaE1DRVcwYjB1VVZvZTM4UjA3dy15MUdOVFlCaXAySkk?oc=5","date":"2024-12-02","type":"pipeline","source":"worldpharmaceuticals.net","summary":"CBC, Mubadala complete acquisition of UCB’s mature business in China - worldpharmaceuticals.net","headline":"CBC, Mubadala complete acquisition of UCB’s mature business in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPeVY0MkZPZU9qUzRTdDVobDBxWVdHNW1rTGdfWl9KN2ZtOHVHbHJUYmlOYW9rLVZGMWJpTWtKOGlYbXg5dE1jSU5hLW4tS1YwZnpRSmZ1T19EVzl4Y2V0UEZ5akV5ZjlYYXJ5bHZpTHlTdVpOT3ctOUdWV054YnhLMENldWU3b3RHcUxwNV9fUHBKQmJfWUFxLTV6OXRrUGdqQVlJZUZGdGtpTThDUDJyRGVBNA?oc=5","date":"2024-10-07","type":"pipeline","source":"Bloomberg.com","summary":"Biotech UCB Mimics Obesity Drug Stocks With Skin Disease Focus - Bloomberg.com","headline":"Biotech UCB Mimics Obesity Drug Stocks With Skin Disease Focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPR0thLTNsT2J2Y1BaQkhURl9SZ2syRzlEUGVGcm43blhfbnVhNGxmSmwtbmpqN1E1dUJrbWNEQjFhYVZmYTBlaUI1Mm41S3FzSnhmUXZNbWY0VExDaGZlVzlpbW5XVnJ4UnR4NjBpdmFzSl9mYk5RbnlOMGVuTGFpcDlYci1vSzRoc0JTQVdTbjU5eUM1OEtaTWNGZUI2eUlaUW0yZjd5RmZQVnJfWmlQYm82LUV4cGJBWFdPM1NTbEg4M2hlaDRGdEV4ajhrT0FMOVpKblJDZWt3dw?oc=5","date":"2024-03-14","type":"pipeline","source":"The Worldfolio","summary":"Pharmicell's bold vision for healthcare transformation - The Worldfolio","headline":"Pharmicell's bold vision for healthcare transformation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBtd2J1WG5aaWNFZkJDQTVCUTI2aXp0aEpZcVItbjNsX2hIZ0pwMjdHWFB2T0x4VjM5aUFUczJjWlhkdTIzZUxkb29BRGhwU2I5MzA5UzU0dVFHYWlRc2h1N19oRURqSl9MbFU0MUhB0gFyQVVfeXFMUHJPSEE0dG1ZemQ0RjBCOHItNWdFSm40czk0LU1oRExaSG9FT3NhendoNVBlNTZ5bHZXSGpaQkFoUW8wQjRFMXVkS2RLa0Jjdjl2TmVDNlVDX1dIR3BIeWFjaXVXZ3B2SlNaTUV0c25hTjR3?oc=5","date":"2023-04-03","type":"pipeline","source":"koreabiomed.com","summary":"'We are committed to advocating for rare disease patients' - koreabiomed.com","headline":"'We are committed to advocating for rare disease patients'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE02SHhtcTV6UTU3VEg0MkFiSWZQbGpiMXJSVzZBWHZldmtYUXNZSzlVZmR4SUJKVEJHU1BsOXptVHZQTjkxZ3RiVTZMUTZOLWhDY1MzZjBxOVc0UFRVVUJyag?oc=5","date":"2020-08-03","type":"pipeline","source":"Pharmaceutical Executive","summary":"Country Report: Korea - Pharmaceutical Executive","headline":"Country Report: Korea","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}